These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15260388)

  • 1. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers.
    Joshi J; Ghaisas S; Vaidya A; Vaidya R; Kamat DV; Bhagwat AN; Bhide S
    J Assoc Physicians India; 2003 Nov; 51():1055-60. PubMed ID: 15260388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the short-term safety and tolerability of a quantified 80 % ethanol extract from the stem bark of Nauclea pobeguinii (PR 259 CT1) in healthy volunteers: a clinical phase I study.
    Mesia K; Cimanga K; Tona L; Mampunza MM; Ntamabyaliro N; Muanda T; Muyembe T; Totté J; Mets T; Pieters L; Vlietinck A
    Planta Med; 2011 Jan; 77(2):111-6. PubMed ID: 20665369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of procoagulant and fibrinogenolytic activity of crude protease fractions of turmeric species.
    Shivalingu BR; Vivek HK; Nafeesa Z; Priya BS; Swamy SN
    J Ethnopharmacol; 2015 Aug; 172():261-4. PubMed ID: 26113180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
    Soleimani V; Sahebkar A; Hosseinzadeh H
    Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ingested turmeric oleoresin on glucose and lipid metabolisms in obese diabetic mice: a DNA microarray study.
    Honda S; Aoki F; Tanaka H; Kishida H; Nishiyama T; Okada S; Matsumoto I; Abe K; Mae T
    J Agric Food Chem; 2006 Nov; 54(24):9055-62. PubMed ID: 17117790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.
    Rosenberg G; Angel I; Kozak A
    Br J Clin Pharmacol; 2005 Jul; 60(1):7-16. PubMed ID: 15963088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer.
    Prucksunand C; Indrasukhsri B; Leethochawalit M; Hungspreugs K
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):208-15. PubMed ID: 11485087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2012 Mar; (571):1-186. PubMed ID: 22441424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of the combination of ginger (Zingiber officinalis), gentian (Gentiana lutea) and turmeric (Curcuma longa) in patients with cancer-associated anorexia.
    Sanatani M; Younus J; Stitt L; Malik N
    J Complement Integr Med; 2015 Mar; 12(1):57-60. PubMed ID: 25324460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety evaluation of turmeric polysaccharide extract: assessment of mutagenicity and acute oral toxicity.
    Velusami CC; Boddapati SR; Hongasandra Srinivasa S; Richard EJ; Joseph JA; Balasubramanian M; Agarwal A
    Biomed Res Int; 2013; 2013():158348. PubMed ID: 24455673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis.
    Hastak K; Lubri N; Jakhi SD; More C; John A; Ghaisas SD; Bhide SV
    Cancer Lett; 1997 Jun; 116(2):265-9. PubMed ID: 9215873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
    Vaughan D; Speed J; Medve R; Andrews JS
    Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of NR-INF-02, an Extract of Curcuma Longa Containing Turmerosaccharides, in Healthy Volunteers: A Randomized, Open-label Clinical Trial.
    Selvi M; Mohan Mv R; Bethapudi B; Mundkinajeddu D; Kumari S
    Altern Ther Health Med; 2022 Feb; 28(2):116-123. PubMed ID: 32827412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.